Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011
暂无分享,去创建一个
A. Armstrong | B. Bebo | Julie Wu | C. Schupp
[1] A. Kimball,et al. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. , 2012, Journal of the American Academy of Dermatology.
[2] E. Berardesca,et al. Health-related quality of life in psoriasis: an analysis of Psocare project patients. , 2011, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.
[3] J. Szepietowski,et al. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. , 2010, Acta dermatovenerologica Croatica : ADC.
[4] F. Aubin,et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[5] D. Symmons,et al. Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies , 2010, Arthritis care & research.
[6] S. Segaert,et al. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[7] S. Feldman,et al. Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study , 2008, Health and quality of life outcomes.
[8] K. Reich,et al. The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab , 2008, Archives of Dermatological Research.
[9] Elizabeth J Horn,et al. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. , 2007, Journal of the American Academy of Dermatology.
[10] Elizabeth J Horn,et al. Association of patient-reported psoriasis severity with income and employment. , 2007, Journal of the American Academy of Dermatology.
[11] Elizabeth J Horn,et al. National Psoriasis Foundation clinical consensus on disease severity. , 2007, Archives of dermatology.
[12] S. Feldman,et al. The negative impact of psoriasis on the workplace , 2006, The Journal of dermatological treatment.
[13] S. Feldman,et al. Decision points for the initiation of systemic treatment for psoriasis. , 2005, Journal of the American Academy of Dermatology.
[14] David J Margolis,et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. , 2004, The journal of investigative dermatology. Symposium proceedings.
[15] M. Gupta,et al. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. , 1998, Cutis.
[16] G. Schmid‐Ott,et al. Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints'. , 1996, Dermatology.